Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico

TORRANCE, Calif., Feb. 2, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. , a leader in sickle cell disease treatment, today announced that it has received marketing authorization from the Puerto...

Related Keywords

Qatar ,Puerto Rico ,United States ,United Arab Emirates ,Kuwait ,Woman ,Bahrain ,Israel ,Americans ,Willis Lee ,George Sekulich ,National Center On Birth Defects ,Committee On Addressing Sickle Cell Disease ,Puerto Rico Department Of Health ,Blueprint For Action National Academy Of Sciences ,Prnewswire Emmaus Life Sciences Inc ,Emmaus Life Sciences ,Centers For Disease ,Emmaus Life Sciences Inc ,Exchange Commission ,Company Contact ,Life Sciences ,Puerto Rico Department ,Emmaus Life ,Prescribing Information ,Sickle Cell Disease ,National Center ,Birth Defects ,Developmental Disabilities ,Disease Control ,Addressing Sickle Cell Disease ,Strategic Plan ,Sciences Press ,Private Securities Litigation Reform Act ,Chief Operating ,Markets ,